Evidence map›Paper›PMID 28451208›Full record

ArticleChemical science2017

Optical control of AMPA receptors using a photoswitchable quinoxaline-2,3-dione antagonist.

David M Barber, Shu-An Liu, Kevin Gottschling, Martin Sumser, Michael Hollmann, Dirk Trauner

Abstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Molecular photoswitches in aqueous environments.Chemical Society reviews · 2021
    Review
  7. Article
  8. Optical control of purinergic signaling.Purinergic signalling · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David M BarberDepartment of Chemistry and Center for Integrated Protein Science , Ludwig Maximilians University Munich , Butenandtstraße 5-13 , 81377 Munich , Germany . Email: dirk.trauner@lmu.de.
Shu-An LiuDepartment of Chemistry and Center for Integrated Protein Science , Ludwig Maximilians University Munich , Butenandtstraße 5-13 , 81377 Munich , Germany . Email: dirk.trauner@lmu.de.
Kevin GottschlingDepartment of Biochemistry I - Receptor Biochemistry , Ruhr-Universität-Bochum , Bochum 44780 , Germany.
Martin SumserDepartment of Chemistry and Center for Integrated Protein Science , Ludwig Maximilians University Munich , Butenandtstraße 5-13 , 81377 Munich , Germany . Email: dirk.trauner@lmu.de.
Michael HollmannDepartment of Biochemistry I - Receptor Biochemistry , Ruhr-Universität-Bochum , Bochum 44780 , Germany.
Dirk TraunerDepartment of Chemistry and Center for Integrated Protein Science , Ludwig Maximilians University Munich , Butenandtstraße 5-13 , 81377 Munich , Germany . Email: dirk.trauner@lmu.de.

Funding

European Research Council 268795
6 · The paper itself

Abstract

AMPA receptors respond to the neurotransmitter glutamate and play a critical role in excitatory neurotransmission. They have been implicated in several psychiatric disorders and have rich pharmacology. Antagonists of AMPA receptors have been explored as drugs and one has even reached the clinic. We now introduce a freely diffusible photoswitchable antagonist that is selective for AMPA receptors and endows them with light-sensitivity. Our photoswitch,

Identifiers

PMID28451208
PMCPMC5358534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.